Belgium
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 378.59 M
|
Dec. 31, 2023 | USD 194.45 | 1.55% |
|
Belgium |
|
2 |
USD 233.66 M
|
Dec. 31, 2023 | USD 22.74 | -0.48% |
|
Belgium |
|
3 |
USD 77.87 M
|
Dec. 31, 2023 | USD 19.73 | 0.25% |
|
Belgium |
|
4 |
USD -35.94 M
|
Dec. 31, 2023 | USD 2.24 | -2.03% |
|
Belgium |
|
5 |
USD -43.10 M
|
Dec. 31, 2023 | USD 1.91 | 0.00% |
|
Belgium |
|
6 |
USD -47.70 M
|
Dec. 31, 2023 | USD 10.80 | 2.86% |
|
Belgium |
The Healthcare company in Belgium with the highest Net Income is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 378.59 M.
The Healthcare company in Belgium with the lowest Net Income is Nyxoah S.A. (NasdaqGM: NYXH) at USD -47.70 M.
The top 10 Healthcare companies in Belgium by Net Income are UCB SA, Galapagos NV, Fagron NV, Sequana Medical NV, MDxHealth SA and Nyxoah S.A..
The bottom 10 Healthcare companies in Belgium by Net Income are Nyxoah S.A., MDxHealth SA, Sequana Medical NV, Fagron NV, Galapagos NV and UCB SA.